中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
De Novo siRNA nanoplatform with NIR-II imaging for treatment of carotid atherosclerotic plaques

文献类型:期刊论文

作者Gao, Jialu2,3,4; Zhu, Hua5; Cai, Huanhuan4; Ding, Qihang1,4; Xiong, Xiaoxing5; Zhang, Tong4; Chen, Bo4; Wang, Wumei4,7; Ju, Xinpeng4,7; Huang, Jianying4
刊名CHEMICAL ENGINEERING JOURNAL
出版日期2025
卷号503页码:13
关键词siRNA delivery Atheromatous plaques NIR-II imaging Multifunctional nanoplatform Epsin1/2
ISSN号1385-8947
DOI10.1016/j.cej.2024.158455
通讯作者Zeng, Xiaodong(xdzeng@baridd.ac.cn) ; Kim, Jong Seung(jongskim@korea.ac.kr) ; Hong, Xuechuan(Xhy78@whu.edu.cn)
英文摘要Reducing foam cell formation and accumulation within plaques is a critical strategy for treating atherosclerosis. Although current lipid-lowering therapies have significantly improved the management of atherosclerosis, the risk of cardiovascular events remains. Thus, it is necessary to explore next-generation therapies to reduce foam cell formation, inflammation, and oxidative stress. To address these challenges, we present an innovative near- infrared II (NIR-II) fluorescent dye coupled with a lesion-targeting peptide, forming a molecular self-assembly nanoplatform for effective in vitro small interfering RNA (siRNA) delivery. This platform downregulates Epsin1/2, a family of ubiquitin-binding endocytic adaptors, upregulates the expressions of ABCG1 and LRP-1 proteins, and markedly reduces foam cell formation. Additionally, this system enables real-time tracking of plaque accumulation, therapeutic response, and efficacy through in vivo noninvasive NIR-II imaging. Systemic siRNA delivery significantly suppresses lipid accumulation, plaque size, and necrotic core area in the carotid plaque model of ApoE-/- mice. These results suggest that this multi-functional nanoplatform could become an effective tool for NIR-II image-guided siRNA delivery for personalized treatment of atherosclerosis.
WOS关键词CHOLESTEROL EFFLUX ; ARTERY PLAQUES ; IN-VIVO ; DELIVERY ; NANOPARTICLES ; INFLAMMATION
资助项目Foundation of Shandong Province[ZR2023MB085] ; Shandong Labora-tory Program[SYS202205] ; Taishan Scholar Project[tsqn202306320] ; Special Project for Significant New Drug Research and Development in the Major National Science and Technology Pro-jects of China[2020ZX09201007] ; National Research Foundation of Korea[2018R1A3B1052702]
WOS研究方向Engineering
语种英语
WOS记录号WOS:001383854800001
出版者ELSEVIER SCIENCE SA
源URL[http://119.78.100.183/handle/2S10ELR8/315169]  
专题中国科学院上海药物研究所
通讯作者Zeng, Xiaodong; Kim, Jong Seung; Hong, Xuechuan
作者单位1.Korea Univ, Dept Chem, Seoul 02841, South Korea
2.Bohai Rim Adv Res Inst Drug Discovery, Shandong Lab Yantai Drug Discovery, Yantai 264117, Peoples R China
3.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
4.Wuhan Univ, Zhongnan Hosp, Sch Pharmaceut Sci, Dept Cardiol,Clin Trial Ctr, Wuhan 430071, Peoples R China
5.Wuhan Univ, Renmin Hosp, Dept Neurosurg, Wuhan 430060, Peoples R China
6.Wuhan Univ, Shenzhen Inst, Shenzhen 518057, Peoples R China
7.Tibet Univ, Sch Ecol & Environm, Key Lab Biodivers & Environm Qinghai Tibetan Plate, Minist Educ, Lhasa 850000, Peoples R China
推荐引用方式
GB/T 7714
Gao, Jialu,Zhu, Hua,Cai, Huanhuan,et al. De Novo siRNA nanoplatform with NIR-II imaging for treatment of carotid atherosclerotic plaques[J]. CHEMICAL ENGINEERING JOURNAL,2025,503:13.
APA Gao, Jialu.,Zhu, Hua.,Cai, Huanhuan.,Ding, Qihang.,Xiong, Xiaoxing.,...&Hong, Xuechuan.(2025).De Novo siRNA nanoplatform with NIR-II imaging for treatment of carotid atherosclerotic plaques.CHEMICAL ENGINEERING JOURNAL,503,13.
MLA Gao, Jialu,et al."De Novo siRNA nanoplatform with NIR-II imaging for treatment of carotid atherosclerotic plaques".CHEMICAL ENGINEERING JOURNAL 503(2025):13.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。